EDGAR Filing Documents for 0001209191-08-050992

Form 3 - Initial statement of beneficial ownership of securities:

SEC Accession No. 0001209191-08-050992

Filing Date

2008-09-08

Accepted

2008-09-08 18:13:22

Documents

Period of Report

2008-02-07

Document Format Files

Seq	Description	Document	Type	Size
1	MAIN DOCUMENT DESCRIPTION	c75167_3x1.html	3
1	MAIN DOCUMENT DESCRIPTION	c75167_3x1.xml	3	1566
2	POWER OF ATTORNEY	c75167_poa.htm	EX-24	3846
	Complete submission text file	0001209191-08-050992.txt		7535

Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 21000

Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 21000 972-4-988-9488

Protalix BioTherapeutics, Inc. (Issuer) CIK: 0001006281 (see all company filings)

IRS No.: 650643773 | State of Incorp.: FL | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O PROTALIX BIOTHERAPEUTICS, INC. 2 SNUNIT STREET, SCIENCE PARK, POB 455 CARMIEL L3 20100

Business Address 974.4.988.9488

Type: 3 | Act: 34 | File No.: 001-33357 | Film No.: 081061752